Works by Abbadessa, G

Results: 11

Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-β1.

Published in:

Rhinology, 2012, v. 50, n. 4, p. 427, doi. 10.4193/rhino11.249

By:

Aversa, S.;
Ondolo, C.;
Abbadessa, G.;
Piccione, F.;
Carriero, V.;
Fulcheri, A.;
Lauria, A.;
De Francia, S.;
Racca, S.

Publication type:

Article

A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.

Published in:

2017

By:

Papadopoulos, K P;
El-Rayes, B F;
Tolcher, A W;
Patnaik, A;
Rasco, D W;
Harvey, R D;
LoRusso, P M;
Sachdev, J C;
Abbadessa, G;
Savage, R E;
Hall, T;
Schwartz, B;
Wang, Y;
Kazakin, J;
Shaib, W L

Publication type:

journal article

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis.

Published in:

British Journal of Cancer, 2013, v. 108, n. 1, p. 21, doi. 10.1038/bjc.2012.556

By:

Santoro, A;
Simonelli, M;
Rodriguez-Lope, C;
Zucali, P;
Camacho, L H;
Granito, A;
Senzer, N;
Rimassa, L;
Abbadessa, G;
Schwartz, B;
Lamar, M;
Savage, R E;
Bruix, J

Publication type:

Article

SAR444245, a non‐alpha IL2, rescues chronic antigen and CAR‐driven T‐cell dysfunction.

Published in:

Hematological Oncology, 2023, v. 41, p. 515, doi. 10.1002/hon.3164_381

By:

Sheikh, I.;
Choi, A.;
Reville, P. K.;
Henderson, J.;
Rojas, E.;
Le, C.;
Okwuchi, C.;
Carrio, R.;
Pate, N.;
Malley, K.;
Bangari, D.;
Gavigan, J.;
Shi, C.;
Liu, B.;
Byers, T.;
Sassoon, I.;
Cucchetti, M.;
Wang, R.;
Agarwal, M.;
Abbadessa, G.

Publication type:

Article

Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab.

Published in:

2021

By:

Abbadessa, G.;
Miele, G.;
Fratta, M.;
Bonavita, S.

Publication type:

Letter

Heidenhain variant of Creutzefeldt–Jackob disease in a patient carrying the V210I mutation with asymmetric MRI abnormalities.

Published in:

2020

By:

Abbadessa, G.;
Lavorgna, L.;
Miele, G.;
Cirillo, M.;
Bonavita, S.

Publication type:

Letter

Digital therapeutics in neurology.

Published in:

2022

By:

Abbadessa, G.;
Brigo, F.;
Clerico, M.;
De Mercanti, S.;
Trojsi, F.;
Tedeschi, G.;
Bonavita, S.;
Lavorgna, L.

Publication type:

Literature Review

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS).

Published in:

Neurogenetics, 2018, v. 19, n. 2, p. 77, doi. 10.1007/s10048-018-0540-1

By:

Ranieri, C.;
Di Tommaso, S.;
Loconte, D. C.;
Grossi, V.;
Sanese, P.;
Bagnulo, R.;
Susca, F. C.;
Forte, G.;
Peserico, A.;
De Luisi, A.;
Bartuli, A.;
Selicorni, A.;
Melis, D.;
Lerone, M.;
Praticò, A. D.;
Abbadessa, G.;
Yu, Y.;
Schwartz, B.;
Ruggieri, Martino;
Simone, Cristiano

Publication type:

Article

Ischemia/reperfusion injury is increased and cardioprotection by a postconditioning protocol is lost as cardiac hypertrophy develops in nandrolone treated rats.

Published in:

Basic Research in Cardiology, 2011, v. 106, n. 3, p. 409, doi. 10.1007/s00395-010-0143-y

By:

Penna, C.;
Tullio, F.;
Perrelli, M.-G.;
Moro, F.;
Abbadessa, G.;
Piccione, F.;
Carriero, V.;
Racca, S.;
Pagliaro, P.

Publication type:

Article

D15 Effects of acetylsalicylic acid administration on liver CYP1A, UGT and antioxidant enzymes in a rat model of dimethylbenzanthracene (DMBA)-induced mammary carcinogenesis.

Published in:

Journal of Veterinary Pharmacology & Therapeutics, 2006, v. 29, n. S1, p. 125, doi. 10.1111/j.1365-2885.2006.00762_17.x

By:

Nebbia, C.;
Spaccamiglio, A.;
Abbadessa, G.;
Racca, S.;
Cantiello, M.;
Dacasto, M.;
Carletti, M.

Publication type:

Article

A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo.

Published in:

Oncogene, 2007, v. 26, n. 13, p. 1829, doi. 10.1038/sj.onc.1209987

By:

Bagella, L.;
Sun, A.;
Tonini, T.;
Abbadessa, G.;
Cottone, G.;
Paggi, M. G.;
De Luca, A.;
Claudio, P. P.;
Giordano, A.

Publication type:

Article